Latest On-Demand Webinars & Online Events

Join us for an exclusive webinar focused on psilocybin licensing and compliance with expert speaker Ryan Pincura, Director of Regulatory Affairs at Tendrel Group.

Attend this webinar to learn how to:
- Create a “digital thread” from the data elements needed for a digital lab
- Connect, develop and understand the context of the data elements to weave a “digital fabric”
- Transform your “digital fabric” into actionable insights for your journey to a digital lab

Detailed and sensitive characterization of ionizable lipids that make up lipid nanoparticles (LNP) and their related impurities is necessary to ensure the quality of mRNA therapies. Additionally, there are mRNA quality attributes such as 5’ capping that directly impact efficacy and safety.

The Problem
LNPs are a valuable tool in the repertoire of gene and vaccine delivery vectors but LNP development is a complex multi-step process.

Join us for an exclusive panel discussion focused on research and development relating to novel chemical entities in the psychedelics industry and some of the viable business models that are emerging in this field.

This Technology Networks event features exclusive talks focused on the most recent and innovative developments in the world of cell and gene therapies. Our expert speakers will highlight the opportunities cell and gene therapies provide for the treatment of disease and injury, including how cell therapies are providing novel solutions for rare diseases such as Duchenne muscular dystrophy.

Far too many forays into managed lab services focus purely on reducing the existing cost of service. While cost reductions can and should be one of the arrows in the service providers’ quiver, it shouldn’t be the only one…or the most important one.

A well-designed and implemented managed services program should be one that grows value over time and constantly evolves to ensure that clients are able to spend more time focused on their core scientific activities.

This webinar will be a helpful exercise for key stakeholders to help them get past the basic economics of selecting a provider and help guide them into partnerships that accelerate adoption and unmask far greater and more impactful value.

This exclusive Technology Networks webinar focuses on the most recent and innovative strategies for therapeutic antibody development and production. Your speaker, Professor Brockwell, will describe the development and use of a new assay to investigate important proteins in disease screening and the biopharmaceutical industry.

Alzheimer’s disease is the most common form of neurodegenerative disease, estimated to contribute to 60–70% of all cases of dementia worldwide. Increasing evidence suggests that neuroinflammation, primarily mediated by microglia, contributes to the onset and progression of Alzheimer’s disease.

Developing a small molecule active pharmaceutical ingredient (API) is often a risky process. Reaching the goal, be it first in human studies or commercial manufacture, requires data and material without incurring unnecessary delays or impact on costs. Therefore, it’s important to start thinking about process steps and scalability early.